NASDAQ · DCGO

DocGo Inc.

$0.63 +$0.03 (+5.72%) 1D Market open

Key Metrics

$58.85M
Market cap
P/E · TTM
$301.71M
Revenue · TTM
−$186.08M
Net income
EPS · TTM $-1.83
Dividend yield
Free cash flow $16.63M
Beta · 1Y 1.83
EBITDA · TTM −$168.20M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 25
    From its Feb 18 high, the share price fell 43%.

    Peak close $0.81 on Feb 18; trough close $0.46 on Jun 25. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -43%
  • Mar 17
    The stock moved +20.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 17
  • Feb 6
    The stock moved +11.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$58.85M
Enterprise value$23.40M
Shares outstanding98.8M
52-wk range$0.45 – $1.78
Avg volume · 20D898.2K
Net cash $35.45M
Book value / share$1.30
IndustryServices-Health Services
ExchangeNASDAQ
About DocGo Inc.
IPO dateNov 8, 2021
Employees3568

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.20
P/FCF3.54
EV/EBITDA
EV/Sales0.08
Graham №

Profitability

Gross
Operating -60.6%
Net -61.7%
FCF 5.5%
ROE / ROIC -82.1% · -201.2%

Financial Health

Current ratio1.79
Quick ratio
Debt / equity0.00
Debt / EBITDA 0.00
Net cash $35.45M
Working capital$60.95M

Cash Flow · TTM

Operating CF $20.14M
Capex −$3.51M
Free cash flow $16.63M
Buybacks $5.08M
Dividends paid
Shareholder yield 8.6%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

-2.1
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings